@article{210dfcf9fa3b45ac86711f3f2267ec9d,
title = "Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer",
abstract = "No standard treatment exists for patients with metastatic colorectal cancer who have progressed after treatment with 5-fluorouracil (5-FU), oxaliplatin, irinotecan and an anti-EGFR antibody. The efficacy and safety of bevacizumab and capecitabine in heavily pre-treated patients with metastatic colorectal cancer were evaluated.",
keywords = "Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms, Deoxycytidine, Disease-Free Survival, Female, Fluorouracil, Humans, Male, Middle Aged, Retrospective Studies, Survival Analysis, Treatment Outcome",
author = "Larsen, {Finn Ole} and Boisen, {Mogens Karsb{\o}l} and Fromm, {Anne-Lene Gunge} and Jensen, {Benny Vittrup}",
year = "2012",
doi = "10.3109/0284186X.2011.614637",
language = "English",
volume = "51",
pages = "231--3",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Medical Journals Sweden AB",
number = "2",
}